GBI names first research leaders at Oxford institute

The Generative Biology Institute at the Ellison Institute of Technology, Oxford, named its first wave of Principal Investigators under Founding Director Professor Jason Chin. The hires mark a major recruitment push aimed at building a global center for generative biology, with plans to translate research into health, climate, food and materials applications.

Why it matters: - The Generative Biology Institute is building a scientific team aimed at making generative biology a practical engine for new medicines, sustainable food, lower-impact materials and environmental solutions. - The institute is positioning Oxford as a potential global hub in a field that could reshape how biology is designed and engineered. - The recruitment gives the institute the core expertise it needs to turn discovery into commercial and societal impact over time.

What happened: - The Generative Biology Institute at the Ellison Institute of Technology, Oxford announced its first wave of Principal Investigators on October 22, 2026. - Professor Jason Chin is the Founding Director of the institute. - Professor Chang Liu joined from the University of California, Irvine. - Dr Leopold Parts joined from the Wellcome Sanger Institute in Cambridge. - Dr Sam Pellock joined after working in Nobel Laureate Professor David Baker’s lab at the University of Washington. - Five researchers joined from the Medical Research Council Laboratory of Molecular Biology in Cambridge: Dr Kiarash Jamali, Dr Rongzhen Tian, Dr Linda van Bijsterveldt, Dr Fabian Rehm and Dr Jerome Zuercher.

The details: - GBI says it aims to be a global centre of excellence in generative biology, an emerging field focused on designing new biological systems rather than only observing or modifying existing ones. - The institute says the field could ultimately enable novel cells, proteins and other biological systems. - The research agenda includes human health and disease, medicine discovery and manufacturing, sustainable food production, climate change, environmental restoration, and new materials and chemicals with lower environmental impact. - Chang Liu is internationally recognised for work in synthetic biology, genetic engineering and directed evolution. - Leopold Parts focuses on learning how to write novel capabilities into eukaryotic cells. - Sam Pellock designs proteins with new functions. - Kiarash Jamali works in machine learning. - Rongzhen Tian works in continuous evolution engineering. - Linda van Bijsterveldt works in chromosome engineering. - Fabian Rehm specialises in directed evolution. - Jerome Zuercher works in synthetic microbiology. - The institute says the recruitment campaign over the past year is now complete. - GBI is part of EIT Oxford, which brings together scientists, technologists, engineers, researchers, educators and innovators across disciplines. - The research portfolio is intended to support GBI’s discovery pipeline and future translation and commercialization efforts. - The institute is backed by technology hubs in high-performance computing, bioinformatics, mass spectrometry, sequencing, flow cytometry, lab automation and lab services. - GBI says the hubs are tightly coupled to the research program and will keep expanding to support the mission.

Between the lines: - EIT Oxford is using senior hires and specialized infrastructure to build not just a lab, but an integrated research-to-application platform. - The institute is leaning into a broader national ambition for the UK to lead in a field with scientific, economic and societal consequences. - Chin framed the effort as a response to biology-centered challenges that require both fundamental science and engineering discipline. - The hires from leading U.S. and UK institutions suggest GBI is trying to concentrate talent from synthetic biology, genome engineering and machine learning in one place.

What's next: - GBI will use its new team and technology hubs to advance a discovery pipeline over the coming years. - The institute plans to translate and commercialise breakthroughs so they can deliver broader societal benefit. - GBI also plans to build collaborations with researchers and institutions internationally. - The institute says it wants to accelerate progress on designing and constructing biological systems constrained only by physical laws and human imagination.

The bottom line: - GBI has completed the first major buildout of its founding scientific team, setting up Oxford as a new base for generative biology research and potential commercialization.